Overexpression of DNMTs is observed in many cancers, including leukemia [4], pancreatic cancer [5], gastric cancer [6], lung cancer [7], and prostate cancer [8], and dysregulated DNMT expression likely is one of the contributing factors leading to aberrant DNA methylation patterns during cancer progression. Here, DNMT1 is linked to prostate cancer.